SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix ($OCUL) is heavily trending amid high anticipation for imminent topline data from its Phase 3 superiority trial of Axpaxli in wet AMD, with the community widely expecting positive results to drive significant upside. Adding to the bullish sentiment, speculation of a sweetened Sanofi buyout offer, following a rejected $16/share bid, is fueling active discussion around potential acquisition prices and a forthcoming short squeeze.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM Integrated Shipping Services is trending as Hapag-Lloyd confirmed an all-cash acquisition offer for $35 per share, sparking fervent community discussion around arbitrage opportunities and the potential for a massive short squeeze. Shareholders are closely watching for regulatory approvals, particularly from the Israeli government, while also anticipating potential dividends before the deal's expected completion.

Norwegian Cruise Line Holdings Ltd. engages in the provision of cruise travel services. It offers cruise experiences for travelers with itineraries in Europe, Asia, Australia, New Zealand, South America, Africa, Canada, Bermuda, Caribbean, Alaska and Hawaii. Its brands include Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. The company was founded in 1966 and is headquartered in Miami, FL.

Norwegian Cruise Line Holdings Ltd

Norwegian Cruise Line Holdings (NCLH) is buzzing after activist investor Elliott Investment Management revealed a substantial stake, aiming to drive performance improvements and help the company catch up to rivals. Community discussions are highly polarized, with many expressing optimism for a turnaround under new leadership while others accuse institutional downgrades of manipulating the stock amidst these strategic shifts.

BlackRock Institutional Trust Company N.A. - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending as recent softer inflation data, flat retail sales, and rising jobless claims intensify community expectations for earlier Fed rate cuts, driving a rally amid a 'flight to safety' narrative. However, fierce debate persists over the reliability of economic data and the long-term trajectory for bond yields.

Builders FirstSource, Inc. engages in the supply and manufacture of building materials, manufactured components, and construction services to professional homebuilders, sub-contractors, remodelers, and consumers. Its products include factory-built roof and floor trusses, wall panels and stairs, vinyl windows, custom millwork and trim, and engineered wood. The company was founded by Kevin P. O'Meara, Donald F. McAleenan and John D. Roach in March 1998 and is headquartered in Irving, TX.

Builders Firstsource Inc

Builders FirstSource is trending as its recent adjusted EPS miss and conservative outlook spark intense community debate over financial health and debt strategy within a volatile housing sector. This sentiment is further complicated by ongoing acquisition speculation and a substantial insider share purchase, leaving investors divided on the company's future trajectory.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is drawing significant attention ahead of its anticipated Phase 3 data release for COMP360 in treatment-resistant depression, a pivotal event that has the community actively debating its potential as a first-to-market psychedelic therapy alongside new FDA clearance for PTSD trials. The broader sector watches closely for implications on regulatory pathways and commercial viability.

BitGo Holdings, Inc. provides cryptocurrency custody solutions. It offers self-custody wallet, qualified custody, liquidity and prime, and infrastructure-as-a-service. The company was founded by Michael Belshe in 2013 and is headquartered in Palo Alto, CA.

BitGo Holdings Inc. - Ordinary Shares - Class A

BitGo is a hot topic following multiple institutional analyst initiations, with firms largely optimistic about its "monopoly" in digital asset custody and infrastructure, while community discussion intensely debates its current valuation amidst sharp volatility since its public offering.

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Mannkind Corp

Mannkind Corp is trending after receiving FDA approval for an updated Afrezza label aimed at simplifying dosing guidance and boosting adoption, with the community actively debating its impact alongside the highly anticipated pediatric approval and the ongoing market launch in India.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Infleqtion Inc. - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X (CCCX) is trending as its merger with quantum technology leader Infleqtion nears, with shares expected to trade as INFQ on the NYSE following shareholder approval and an exceptionally low redemption rate. The community is highly bullish on Infleqtion's validated technology, including recent NASA and U.S. DOE contracts, and anticipates substantial upside from its limited post-merger public float, viewing it as significantly undervalued compared to sector peers.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is trending due to overwhelming bearish sentiment, as the stock repeatedly hits multi-year lows, driving widespread community frustration with its persistent decline and management's perceived inaction. Investors are also highly focused on its anticipated earnings report, with much debate surrounding the implications of its delayed release and intensifying competition in the ad-tech sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Infosys Q1 FY26 Results: Profit +9%, Revenue +8%
📲 Join the FIS family!

• Revenue: ₹42,279 Cr (+8% YoY) – Strong top-line growth
• Net Profit: ₹6,921 Cr (+9% YoY) – Beat expectations
• EBITDA: Not disclosed in summary (operating margin view below)
• Operating Margin: ~20.8% (vs ~21.1% YoY) – Slight compression
• Deal Wins (TCV): $3.8 Bn – Robust new deal momentum
🧠 FIS Take: Positive
Infosys delivered a solid quarter with healthy revenue and profit growth, aided by strong deal wins and steady client traction in BFSI and digital services. Slight margin dip reflects expected pressure; FY26 guidance was prudently raised. Focus ahead: deal ramp-up, margin recovery, and free cash flow.

$INFY.NSE

Anubhav Mishra

Bala Yogesh

StockTwits For Android 

Infosys Ltd

Infosys is trending following a strategic collaboration with AI research firm Anthropic, which aims to accelerate advanced enterprise AI solutions in highly regulated sectors. This partnership is fueling optimism and helping to ease prevalent AI disruption concerns across the broader IT sector.

Infosys Q1 FY26 Results: Profit +9%, Revenue +8%
📲 Join the FIS family!

• Revenue: ₹42,279 Cr (+8% YoY) – Strong top-line growth
• Net Profit: ₹6,921 Cr (+9% YoY) – Beat expectations
• EBITDA: Not disclosed in summary (operating margin view below)
• Operating Margin: ~20.8% (vs ~21.1% YoY) – Slight compression
• Deal Wins (TCV): $3.8 Bn – Robust new deal momentum
🧠 FIS Take: Positive
Infosys delivered a solid quarter with healthy revenue and profit growth, aided by strong deal wins and steady client traction in BFSI and digital services. Slight margin dip reflects expected pressure; FY26 guidance was prudently raised. Focus ahead: deal ramp-up, margin recovery, and free cash flow.

